CPC A61K 31/4188 (2013.01) [A61K 31/4709 (2013.01); A61P 13/12 (2018.01)] | 15 Claims |
1. A method for treating a patient with chronic kidney disease (CKD), the method comprising administering compound 29A to the patient
![]() wherein compound 29A is administered once daily in an amount of 3 mg, 10 mg or 20 mg, and
wherein the treatment provides an improvement in albumin creatinine ratio (UACR) measured in First Morning Void (FMV) urine.
|